1. Home
  2. PTCT vs LUMN Comparison

PTCT vs LUMN Comparison

Compare PTCT & LUMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • LUMN
  • Stock Information
  • Founded
  • PTCT 1998
  • LUMN 1968
  • Country
  • PTCT United States
  • LUMN United States
  • Employees
  • PTCT N/A
  • LUMN N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • LUMN Telecommunications Equipment
  • Sector
  • PTCT Health Care
  • LUMN Telecommunications
  • Exchange
  • PTCT Nasdaq
  • LUMN Nasdaq
  • Market Cap
  • PTCT 3.7B
  • LUMN 4.1B
  • IPO Year
  • PTCT 2013
  • LUMN 1972
  • Fundamental
  • Price
  • PTCT $50.34
  • LUMN $3.95
  • Analyst Decision
  • PTCT Buy
  • LUMN Hold
  • Analyst Count
  • PTCT 14
  • LUMN 9
  • Target Price
  • PTCT $63.57
  • LUMN $4.78
  • AVG Volume (30 Days)
  • PTCT 939.9K
  • LUMN 11.3M
  • Earning Date
  • PTCT 08-07-2025
  • LUMN 08-05-2025
  • Dividend Yield
  • PTCT N/A
  • LUMN N/A
  • EPS Growth
  • PTCT N/A
  • LUMN N/A
  • EPS
  • PTCT 7.51
  • LUMN N/A
  • Revenue
  • PTCT $1,772,758,000.00
  • LUMN $13,000,000,000.00
  • Revenue This Year
  • PTCT $121.50
  • LUMN N/A
  • Revenue Next Year
  • PTCT N/A
  • LUMN N/A
  • P/E Ratio
  • PTCT $6.72
  • LUMN N/A
  • Revenue Growth
  • PTCT 91.12
  • LUMN N/A
  • 52 Week Low
  • PTCT $28.72
  • LUMN $0.97
  • 52 Week High
  • PTCT $58.38
  • LUMN $10.33
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 54.78
  • LUMN 47.59
  • Support Level
  • PTCT $49.47
  • LUMN $3.98
  • Resistance Level
  • PTCT $52.45
  • LUMN $4.26
  • Average True Range (ATR)
  • PTCT 1.54
  • LUMN 0.22
  • MACD
  • PTCT -0.09
  • LUMN -0.02
  • Stochastic Oscillator
  • PTCT 49.17
  • LUMN 29.03

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About LUMN Lumen Technologies Inc.

With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 in 2017 and divestiture of much of its incumbent local exchange carrier, or ILEC, business in 2022 have shifted the company's operations away from its legacy consumer business and toward enterprises (now about 75% of revenue). Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen has announced the sale of its consumer fiber network, but will maintain and harvest its legacy consumer copper network.

Share on Social Networks: